Sybren L N Maas

10PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Molecular targetsRadiation therapyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 14, 2026
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

|Jun 10, 2026
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

|Mar 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Rosa Luning, Sybren L N Maas, Pim J French

|Feb 09, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

Sybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao

|Nov 21, 2025
Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas.

Anders Broechner, Andrea Daniela Maier, Christian Mirian

|Jul 27, 2024
Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma Spheroids.

Thom G A Reuvers, Vivian Grandia, Renata M C Brandt

Pageof 2

Frequent Collaborators

5 joint publications

Felix Sahm

4 joint publications

Philipp Sievers

4 joint publications

Andreas von Deimling

4 joint publications

Wolfgang Wick